Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|5|692-701

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.5, 2014-03, pp. : 692-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO‐AB 31/05)

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 429-436

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimum Dose of Once‐Daily Oxybutynin Patch in Japanese Patients with Overactive Bladder: A Randomized Double‐Blind Trial Versus Placebo

By  

LUTS, Vol. 8, Iss. 3, 2016-09 ,pp. : 150-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2684-2693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 10, 2015-10 ,pp. : 1050-1056

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

By Barzilai Nir   Guo Hua   Mahoney Erin M.   Caporossi Suzanne   Golm Gregory T.   Langdon Ronald B.   Williams-Herman Debora   Kaufman Keith D.   Amatruda John M.   Goldstein Barry J.   Steinberg Helmut  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1049-1058

Informa Healthcare

Access to resources Recommend Favorite